Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.

Its prospectus says that the IPO will fund phase 1 and phase ... in the footsteps of obesity drug developer Metsera and genetic medicines developer Maze Therapeutics, which filed to list on ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

Northpointe Bancshares, Inc. operates as the bank holding company for Northpointe Bank provides various banking products and services. It offers noninterest-bearing accounts, savings, money-market ...

After hours: February 28 at 4:05:05 p.m. EST ...

Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.

IPO content provided by Renaissance Capital LLC, manager of the IPO-focused ETFs (tickers: IPO, IPOs).

After hours: February 28 at 4:57:35 p.m. EST ...